Login

TI Ref No :	521781193
Description :	Conclusion Of Non-exclusive Discount Agreements Pursuant To § 130a Abs.8 Sgb V With The Active Substance Natalizumab Ifk, Medicines
Date :	2025-08-19
Deadline :	2026-02-14
Document Type :	Tenders